IDEAYA Biosciences Announces Inducement Grants
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company, announced that the Compensation Committee of its Board of Directors granted non-qualified stock options to two newly hired employees.
The stock options are for an aggregate of 73,500 shares of the Company's common stock, with an exercise price of $31.60 per share, equal to the closing price on The Nasdaq Global Select Market on the date of grant.
The grants were made under the IDEAYA Biosciences, Inc. stock option plan, as required by Nasdaq Listing Rule 5635(c)(4), on October 30, 2025.
No additional information was provided.
Author summary: IDEAYA Biosciences grants stock options.
More News
- Celebrity-approved Halloween nail ideas for spooky season – Scratch
- The EVERY Co and Onego Bio eyed merger before IP talks went south, court docs reveal
- Flyers flying under the radar — and deserve a packed house again | NorthPennNow
- Rashid three-for, Zadran fifty lead Afghanistan to series win
- University of Glasgow - University news - Double award win for UofG knowledge transfer partnership with Soapworks Ltd
- How Olivia Dean Positioned Herself For a Global Breakout With ‘The Art of Loving’
- Madden 26 Player Ratings For Week 9 - Biggest Winners & Losers
- Philadelphia Eagles QB Jalen Hurts Dressed As God For Halloween
- Topsoe launches 500MW electrolyser facility in Denmark
- Where can you find Newcastle’s Christmas lights switch on event? – Spark Sunderland